BACKGROUND: Endocrine treatment is one of the most effective therapies for estrogen receptor-positive breast cancer. However, most tumors will develop resistance to endocrine therapy as the cancer progresses. This review focuses on the mechanisms and markers of endocrine-resistant breast cancer. In addition, current and future strategies to overcome endocrine resistance are discussed. SUMMARY: Several molecular mechanisms of endocrine resistance have been identified, including alterations in the ESR1 gene or in the PIK3CA/mTOR pathway. Meanwhile, CDK4/6, mTOR, and PI3K inhibition have shown to improve the efficacy of endocrine treatment and new promising approaches are being developed. KEY MESSAGE: Overcoming primary or acquired resistance to endocrine treatment remains a major challenge. Since the molecular mechanisms of endocrine resistance are manifold, optimal combination and sequencing strategies will have to be developed in the future.
BACKGROUND: Endocrine treatment is one of the most effective therapies for estrogen receptor-positive breast cancer. However, most tumors will develop resistance to endocrine therapy as the cancer progresses. This review focuses on the mechanisms and markers of endocrine-resistant breast cancer. In addition, current and future strategies to overcome endocrine resistance are discussed. SUMMARY: Several molecular mechanisms of endocrine resistance have been identified, including alterations in the ESR1 gene or in the PIK3CA/mTOR pathway. Meanwhile, CDK4/6, mTOR, and PI3K inhibition have shown to improve the efficacy of endocrine treatment and new promising approaches are being developed. KEY MESSAGE: Overcoming primary or acquired resistance to endocrine treatment remains a major challenge. Since the molecular mechanisms of endocrine resistance are manifold, optimal combination and sequencing strategies will have to be developed in the future.
Authors: John F R Robertson; Igor M Bondarenko; Ekaterina Trishkina; Mikhail Dvorkin; Lawrence Panasci; Alexey Manikhas; Yaroslav Shparyk; Servando Cardona-Huerta; Kwok-Leung Cheung; Manuel Jesus Philco-Salas; Manuel Ruiz-Borrego; Zhimin Shao; Shinzaburo Noguchi; Jacqui Rowbottom; Mary Stuart; Lynda M Grinsted; Mehdi Fazal; Matthew J Ellis Journal: Lancet Date: 2016-11-29 Impact factor: 79.321
Authors: Linda Sofie Lindström; Eva Karlsson; Ulla M Wilking; Ulla Johansson; Johan Hartman; Elisabet Kerstin Lidbrink; Thomas Hatschek; Lambert Skoog; Jonas Bergh Journal: J Clin Oncol Date: 2012-06-18 Impact factor: 44.544
Authors: Emily M Fox; Todd W Miller; Justin M Balko; Maria G Kuba; Violeta Sánchez; R Adam Smith; Shuying Liu; Ana María González-Angulo; Gordon B Mills; Fei Ye; Yu Shyr; H Charles Manning; Elizabeth Buck; Carlos L Arteaga Journal: Cancer Res Date: 2011-09-09 Impact factor: 12.701
Authors: John F R Robertson; Justin P O Lindemann; Antonio Llombart-Cussac; Janusz Rolski; David Feltl; John Dewar; Laura Emerson; Andrew Dean; Matthew J Ellis Journal: Breast Cancer Res Treat Date: 2012-10-13 Impact factor: 4.872
Authors: Gabriel N Hortobagyi; David Chen; Martine Piccart; Hope S Rugo; Howard A Burris; Kathleen I Pritchard; Mario Campone; Shinzaburo Noguchi; Alejandra T Perez; Ines Deleu; Mikhail Shtivelband; Norikazu Masuda; Shaker Dakhil; Ian Anderson; Douglas M Robinson; Wei He; Abhishek Garg; E Robert McDonald; Hans Bitter; Alan Huang; Tetiana Taran; Thomas Bachelot; Fabienne Lebrun; David Lebwohl; José Baselga Journal: J Clin Oncol Date: 2015-10-26 Impact factor: 44.544
Authors: H S Rugo; R S Finn; V Diéras; J Ettl; O Lipatov; A A Joy; N Harbeck; A Castrellon; S Iyer; D R Lu; A Mori; E R Gauthier; C Huang Bartlett; K A Gelmon; D J Slamon Journal: Breast Cancer Res Treat Date: 2019-01-10 Impact factor: 4.872
Authors: Dan R Robinson; Yi-Mi Wu; Pankaj Vats; Fengyun Su; Robert J Lonigro; Xuhong Cao; Shanker Kalyana-Sundaram; Rui Wang; Yu Ning; Lynda Hodges; Amy Gursky; Javed Siddiqui; Scott A Tomlins; Sameek Roychowdhury; Kenneth J Pienta; Scott Y Kim; J Scott Roberts; James M Rae; Catherine H Van Poznak; Daniel F Hayes; Rashmi Chugh; Lakshmi P Kunju; Moshe Talpaz; Anne F Schott; Arul M Chinnaiyan Journal: Nat Genet Date: 2013-11-03 Impact factor: 38.330
Authors: Julie A Means-Powell; Ingrid A Mayer; Roohi Ismail-Khan; Luis Del Valle; Debra Tonetti; Vandana G Abramson; Melinda S Sanders; Richard M Lush; Claudia Sorrentino; Samarpan Majumder; Lucio Miele Journal: Clin Breast Cancer Date: 2021-10-28 Impact factor: 3.078
Authors: Kate M Moore; Vera Cerqueira; Kenneth G MacLeod; Peter Mullen; Richard L Hayward; Simon Green; David J Harrison; David A Cameron; Simon P Langdon Journal: Explor Target Antitumor Ther Date: 2022-02-28